Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

By Hymes Jeffrey   Bickimer Tammy   Jackson James H.   Bookhart Brahim K.   Mody Samir H.   Tak Piech Catherine  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1931-1937

Informa Healthcare

Access to resources Recommend Favorite

Prevalence, Patterns of Treatment, and Control of Hypertension in Predialysis Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 120, Iss. 3, 2012-06 ,pp. : c147-c155

Karger

Access to resources Recommend Favorite

Cutaneuos findings in patients with predialysis chronic kidney disease

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1609-1613

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dosing patterns, treatment costs, and frequency of physician visits in adults with cancer receiving erythropoietic agents in managed care organizations

By Lefebvre Patrick   Gosselin Antoine   McKenzie R. Scott   Mody Samir H.   Piech Catherine Tak   Duh Mei Sheng  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1623-1631

Informa Healthcare

Access to resources Recommend Favorite

Treatment of renal anaemia with erythropoiesis‐stimulating agents in predialysis chronic kidney disease patients: Haemoglobin profile during the 6 months before initiation of dialysis

By  

NEPHROLOGY, Vol. 20, Iss. S4, 2015-12 ,pp. : 29-32

John Wiley & Sons Inc

Access to resources Recommend Favorite